Profile and Organisation

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.

Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Organisation

Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.

Click here to download organisation chart with management structure and fields of activity.

Business operations are the responsibility of the subgroups:

Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.

Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.

Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.

Central service functions are combined into three service companies:

Bayer Business Services is the Bayer Group’s international competence center for it-based services.

Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver.

Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:	four members, Chairman: Dr. Marijn Dekkers
Supervisory Board:	20 members, Chairman: Werner Wenning

Products

The Bayer Group markets some 5,000 products. Best-sellers include:

in the health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avelox®/Avalox®
in the nutrition field: Confidor®/ Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
in the field of high-tech materials: Makrolon®, Bayblend®, BaySystems® Footwear, Desmodur®/Desmophen®

Locations

Bayer is represented around the world by about 280 companies*. Global headquarters are in Leverkusen, Germany.

*fully consolidated subsidiaries (as of Dec. 31, 2012)

Workforce

On December 31, 2012, the Bayer Group had 110,500 employees worldwide (2011: 111,800). In Germany we had 34,600 employees, who made up 31.3 percent of the Group workforce.

Bayer Stock

included in nearly all the major share indices
traded on all German stock exchanges
dividend per share: EUR 1.65 (2012)

Bayer Group Key Data

Bayer Group	2011 in EUR Million	2012 in EUR Million	Change in %
Sales	36,528	39,760	8.8
EBIT¹	4,149	3,960	-4.6
EBIT before special items²	5,025	5,671	12.9
EBITDA³	6,918	6,920	0.0
EBITDA before special items²	4,452	8,284	8.8
Income before income taxes	3,363	3,248	-3.4
Net income	2,470	2,446	-1.0
Earnings per share (€)⁵	2.99	2.96	-1.0
Gross cash flow⁷	5,172	4,599	-11.1
Net cash flow⁸	5,060	4,532	-10.4
Capital expenditures as per segment table	1,666	2,012	20.8
Research and development expenses	2,932	3,013	2.8
Dividend per Bayer AG share (€)	1.65	1.90	15.2